ALTAVANT SCIENCES TO PRESENT DATA AT ISHLT SHOWING POTENCY AND DISTRIBUTION OF BRONCHIOLITIS OBLITERANS CANDIDATE, ALTA-2530

/PRNewswire/ -- Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases,...

Related Keywords

Boston ,Massachusetts ,United States ,Switzerland ,Sumitomo Dainippon Pharma ,Sumitovant Biopharma ,Linkedin ,Prnewswire Altavant Sciences ,Twitter ,International Society For Heart Lung Transplantation ,Altavant Sciences ,Insights For Drug Development ,Sumitovant Biopharma Ltd ,Johnb Hynes Memorial Convention Center ,Receptor Blockage Supporting Development ,International Society ,Lung Transplantation ,Chronic Lung Allograft Dysfunction ,Provide Essential Insights ,Memorial Convention Center ,Demonstrates Distribution ,Distal Regions ,High Affinity ,Blockage Supporting Development ,Sumitomo Dainippon ,